Birdwatch Note
2024-03-08 00:24:09 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
論文には「自己報告の回復」self-reported recoveryではと書かれていますが、そのあとに「自己報告された回復結果の小さな違いの知見は、薬物がメディアで顕著に取り上げられたため、イベルメクチン治療からの利益に対する高い期待の影響を受けた可能性があります。」と述べられています。 他の論文では、「COVID-19のイベルメクチンは、回復、入院、または長期的な結果において臨床的に有意義な改善をもたらす可能性は低い。ワクチン接種を受けたコミュニティ集団におけるSARS-Cov-2感染に対するイベルメクチンのさらなる試験は不当であると思われる。」 https://pubmed.ncbi.nlm.nih.gov/38431155/
Written by 875646048C0DB6E5264A40CAEF6432EAC8777220EC640E70C2563610E0130F5D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1765740769850392826
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1765896248526299605
- noteId - 1765896248526299605
- participantId -
- noteAuthorParticipantId - 875646048C0DB6E5264A40CAEF6432EAC8777220EC640E70C2563610E0130F5D Participant Details
- createdAtMillis - 1709857449071
- tweetId - 1765740769850392826
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 論文には「自己報告の回復」self-reported recoveryではと書かれていますが、そのあとに「自己報告された回復結果の小さな違いの知見は、薬物がメディアで顕著に取り上げられたため、イベルメクチン治療からの利益に対する高い期待の影響を受けた可能性があります。」と述べられています。 他の論文では、「COVID-19のイベルメクチンは、回復、入院、または長期的な結果において臨床的に有意義な改善をもたらす可能性は低い。ワクチン接種を受けたコミュニティ集団におけるSARS-Cov-2感染に対するイベルメクチンのさらなる試験は不当であると思われる。」 https://pubmed.ncbi.nlm.nih.gov/38431155/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-03-08 00:24:09 UTC (1709857449071) |
2024-03-08 08:04:28 UTC (1709885068612) |
CURRENTLY_RATED_HELPFUL | 2024-03-10 02:46:15 UTC (1710038775311) |
CURRENTLY_RATED_HELPFUL | 2024-03-08 08:04:28 UTC (1709885068612) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-03-08 05:34:15 -0600 | Rating Details | |
| 2024-03-08 00:07:27 -0600 | Rating Details | |
| 2024-03-07 23:54:34 -0600 | Rating Details | |
| 2024-03-07 22:20:01 -0600 | Rating Details | |
| 2024-03-07 22:14:20 -0600 | Rating Details | |
| 2024-03-07 21:59:09 -0600 | Rating Details | |
| 2024-03-07 21:53:39 -0600 | Rating Details | |
| 2024-03-07 21:41:45 -0600 | Rating Details | |
| 2024-03-07 20:24:00 -0600 | Rating Details | |
| 2024-03-07 18:41:55 -0600 | Rating Details | |
| 2024-03-07 18:33:26 -0600 | Rating Details | |
| 2024-03-07 18:32:51 -0600 | Rating Details | |
| 2024-03-08 19:52:29 -0600 | Rating Details | |
| 2024-03-08 17:49:20 -0600 | Rating Details | |
| 2024-03-08 05:38:22 -0600 | Rating Details | |
| 2024-03-08 00:06:18 -0600 | Rating Details | |
| 2024-03-07 23:35:18 -0600 | Rating Details | |
| 2024-03-07 23:15:11 -0600 | Rating Details | |
| 2024-03-07 22:56:19 -0600 | Rating Details | |
| 2024-03-07 21:48:42 -0600 | Rating Details | |
| 2024-03-07 21:44:41 -0600 | Rating Details | |
| 2024-03-07 21:05:15 -0600 | Rating Details | |
| 2024-03-07 20:37:13 -0600 | Rating Details | |
| 2024-03-07 19:43:41 -0600 | Rating Details | |
| 2024-03-07 19:12:31 -0600 | Rating Details | |
| 2024-03-07 19:12:02 -0600 | Rating Details | |
| 2024-03-07 19:11:34 -0600 | Rating Details | |
| 2024-03-07 18:49:26 -0600 | Rating Details | |
| 2024-03-07 18:47:47 -0600 | Rating Details | |
| 2024-03-12 01:49:25 -0500 | Rating Details | |
| 2024-03-11 22:37:23 -0500 | Rating Details | |
| 2024-03-11 03:13:38 -0500 | Rating Details | |
| 2024-03-10 19:02:47 -0500 | Rating Details | |
| 2024-03-08 20:39:26 -0600 | Rating Details | |
| 2024-03-08 13:43:12 -0600 | Rating Details | |
| 2024-03-08 04:56:00 -0600 | Rating Details | |
| 2024-03-08 04:28:31 -0600 | Rating Details | |
| 2024-03-08 02:34:01 -0600 | Rating Details | |
| 2024-03-08 01:02:00 -0600 | Rating Details | |
| 2024-03-08 00:17:04 -0600 | Rating Details | |
| 2024-03-07 23:40:57 -0600 | Rating Details | |
| 2024-03-07 22:12:21 -0600 | Rating Details | |
| 2024-03-07 21:17:55 -0600 | Rating Details | |
| 2024-03-07 20:58:13 -0600 | Rating Details | |
| 2024-03-07 19:12:18 -0600 | Rating Details | |
| 2024-03-07 19:03:08 -0600 | Rating Details | |
| 2024-03-11 03:29:55 -0500 | Rating Details | |
| 2024-03-11 02:35:06 -0500 | Rating Details |